|
|
ESTECH Launches the COBRA® Adhere XL,
a New Cardiac Ablation Product offering an Alternative Treatment with Proven Safety and Effectiveness
Florida Surgeons Conduct First Minimally Invasive Stand Alone Ablation Procedure for treatment of Atrial Fibrillation using the new device.
Philadelphia, PA, May 1, 2006-At The American Association for Thoracic Surgery Annual Meeting, ESTECH
announced the launch of the COBRA Adhere XL. This new alternative for
cardiac ablation has been proven to provide safe and effective cardiac
ablation during its limited release period. Robert R. Lazzara, M.D.,
and J. Crayton Pruitt, M.D., both with Cardiac Surgical Associates in
Tampa, Florida, report continued success with a series of minimally
invasive cardiac ablation procedures using COBRA Adhere XL, a new tool
in the clinically proven COBRA Line of Radio Frequency (RF) Devices for
cardiac ablation.
Dr. Lazzara reports, "We used the COBRA Adhere XL in a least invasive
method, accessing the heart with only three small punctures between the
ribs. The device offers the advantage of suction adherence to the
surface of the heart, efficiently delivering ablation therapy, requiring
only a few minutes of time to deliver the treatment, in a hands free
environment".
ESTECH President and CEO, Art Bertolero said, "The COBRA Adhere XL
represents a significant new option for patients requiring cardiac
ablation, with specific indications for Atrial Fibrillation in Europe,
and Cardiac Ablation in the U.S. In peer reviewed studies conducted on
atrial fibrillation patients, the COBRA technology has produced the
highest ablation success rates, and early results with the COBRA Adhere
products show success rates approaching 90%."
About COBRA Technology
COBRA technology uses a unique intelligent temperature based system that
provides both optimal and reproducible results by regulating the RF
energy.
The ESTECH COBRA Adhere XL and the COBRA AFfirm have recently received
US FDA 510(k) marketing clearance. The COBRA Adhere Surgical System
received the CE mark with an indication for treatment of AF. The COBRA
Adhere is used by surgeons to make lesions on the heart that block the
electrical impulses that cause AF.
The COBRA Adhere XL will enable a minimally invasive technique to treat
AF. The COBRA AFfirm is the first RF product accessory to be intended
for the treatment of cardiac arrhythmias in the United States. It
provides a means for immediately evaluating the effectiveness of AF
treatment procedures.
About ESTECH
ESTECH headquartered in San Ramon, CA offers tools for least invasive
techniques and traditional approaches to the procedures that cardiac
surgeons do every day - coronary artery bypass, valve surgery, atrial
ablation and surgical treatment of congestive heart failure.
Note to Editors: ESTECH, Inc. and "Cobra" are trademarks owned by or
licensed to Endoscopic Technologies, Inc.
Back to News
|
|
|
|